Health Care & Life Sciences » Pharmaceuticals | Wooridul Pharmaceutical Ltd.

Wooridul Pharmaceutical Ltd.

Wooridul Pharmaceutical Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW342.91
Market Cap
KRW80.47 B
Shares Outstanding
11.57 M
Public Float
10.61 M

Profile

Address
50 Pharmaceutical Ind. Complex 2-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.wooridulpharm.com
Updated 07/08/2019
Wooridul Pharmaceutical Ltd. engages in the development and production of medicaments. It operates through the following business divisions: ETC Drug, OTC Drug, Obesity Drug and Health Food. The company was founded on August 22, 1966 and is headquartered in Hwaseong, South Korea.

Financials

View All
Created with Highcharts 5.0.14Wooridul Pharmaceutical Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.3 6993 6994 5844 5842 0672 0673 4523 4524 3204 3202013201420152016201701k2k3k4k5k
Created with Highcharts 5.0.14Wooridul Pharmaceutical Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.38 97138 97144 20344 20360 40560 40571 54671 54679 89479 89420132014201520162017020k40k60k80k100k

Nam-Hyun Ryu
Chief Executive Officer & Director
Seung-Ho Jeong
Director & Vice President